{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:17:20Z","timestamp":1788952640237,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010657","name":"Carl Marshall and Mildred Almen Reeves Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY031209"],"award-info":[{"award-number":["R01EY031209"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1K08EY031800-01"],"award-info":[{"award-number":["1K08EY031800-01"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.dmd.2025.100145","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:31:41Z","timestamp":1754955101000},"page":"100145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of hydrolase activity in ocular tissues of humans and preclinical species"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4379-917X","authenticated-orcid":false,"given":"Mengyue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8677-9737","authenticated-orcid":false,"given":"Donglu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5283-8070","authenticated-orcid":false,"given":"Robert S.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0283-6816","authenticated-orcid":false,"given":"Lionel","family":"Cheruzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-9288","authenticated-orcid":false,"given":"S. Cyrus","family":"Khojasteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6849-7290","authenticated-orcid":false,"given":"Hsu-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Adaligil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Treefa","family":"Shwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3802-3868","authenticated-orcid":false,"given":"Leah A.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0310-6129","authenticated-orcid":false,"given":"Ivana K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7549-2658","authenticated-orcid":false,"given":"Bin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dmd.2025.100145_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv Transl Res"},{"issue":"10","key":"10.1016\/j.dmd.2025.100145_bib2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2174\/1389200216666150401110610","article-title":"Interplay of drug-metabolizing enzymes and transporters in drug absorption and disposition","volume":"15","author":"Shi","year":"2014","journal-title":"Curr Drug Metab"},{"issue":"6","key":"10.1016\/j.dmd.2025.100145_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/1389200043335342","article-title":"Role of metabolism in ocular drug delivery","volume":"5","author":"Duvvuri","year":"2004","journal-title":"Curr Drug Metab"},{"issue":"10","key":"10.1016\/j.dmd.2025.100145_bib4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1124\/dmd.122.001072","article-title":"Challenges and opportunities in P450 research on the eye","volume":"51","author":"Pikuleva","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2025.100145_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/03602532.2024.2368247","article-title":"Ocular drug-metabolizing enzymes: focus on esterases","volume":"56","author":"Hammid","year":"2024","journal-title":"Drug Metab Rev"},{"issue":"2","key":"10.1016\/j.dmd.2025.100145_bib6","first-page":"175","article-title":"Ocular prodrugs: attributes and challenges","volume":"16","author":"Kour","year":"2021","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.dmd.2025.100145_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121361","article-title":"Ocular metabolism and distribution of drugs in the rabbit eye: quantitative assessment after intracameral and intravitreal administrations","volume":"613","author":"Del Amo","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.dmd.2025.100145_bib8","series-title":"StatPearls [Internet]","article-title":"Latanoprost","author":"Tripathy","year":"2025"},{"key":"10.1016\/j.dmd.2025.100145_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.addr.2018.01.008","article-title":"Ocular delivery of proteins and peptides: challenges and novel formulation approaches","volume":"126","author":"Mandal","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.dmd.2025.100145_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114441","article-title":"Protein and polypeptide mediated delivery to the eye","volume":"188","author":"Attia","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"10326","key":"10.1016\/j.dmd.2025.100145_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"issue":"10326","key":"10.1016\/j.dmd.2025.100145_bib12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.dmd.2025.100145_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.dmd.2025.100145_bib14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/cells12071071","article-title":"Ocular delivery of therapeutic agents by cell-penetrating peptides","volume":"12","author":"Nh\u00e0n","year":"2023","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.dmd.2025.100145_bib15","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1124\/dmd.111.041335","article-title":"Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human","volume":"39","author":"Williams","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2025.100145_bib16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/acs.molpharmaceut.0c01154","article-title":"Carboxylesterase activities and protein expression in rabbit and pig ocular tissues","volume":"18","author":"Hammid","year":"2021","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1016\/j.dmd.2025.100145_bib17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1124\/dmd.122.000993","article-title":"Activity and expression of carboxylesterases and arylacetamide deacetylase in human ocular tissues","volume":"50","author":"Hammid","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmd.2025.100145_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4103\/ijmr.IJMR_1284_14","article-title":"Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina","volume":"145","author":"Bharathidevi","year":"2017","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.dmd.2025.100145_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/03602532.2017.1322609","article-title":"Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes","volume":"49","author":"Argikar","year":"2017","journal-title":"Drug Metab Rev"},{"issue":"7","key":"10.1016\/j.dmd.2025.100145_bib20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1124\/dmd.120.000297","article-title":"Comparative proteomics analysis of the postmitochondrial supernatant fraction of human lens-free whole eye and liver","volume":"49","author":"Balhara","year":"2021","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.dmd.2025.100145_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100099","article-title":"Comparative transcriptomic profiling of drug-metabolizing enzymes and drug transporters in rabbit ocular subtissues, liver, and duodenum","volume":"53","author":"Li","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmd.2025.100145_bib22","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.xphs.2017.03.008","article-title":"Do we need to study metabolism and distribution in the eye: why, when, and are we there yet?","volume":"106","author":"Argikar","year":"2017","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.dmd.2025.100145_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1091581819867929","article-title":"Biochemical and electroretinographic characterization of the minipig eye in the context of drug safety investigations","volume":"38","author":"Negro Silva","year":"2019","journal-title":"Int J Toxicol"},{"issue":"23","key":"10.1016\/j.dmd.2025.100145_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316661","article-title":"Animal models in eye research: focus on corneal pathologies","volume":"24","author":"Loiseau","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"Pt B","key":"10.1016\/j.dmd.2025.100145_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpb.2015.04.033","article-title":"Evaluation of protein drug stability with vitreous humor in a novel ex-vivo intraocular model","volume":"95","author":"Patel","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.dmd.2025.100145_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11419-015-0294-5","article-title":"Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review","volume":"34","author":"B\u00e9valot","year":"2016","journal-title":"Forensic Toxicol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100145_bib27","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1167\/iovs.18-24254","article-title":"The Utah protocol for postmortem eye phenotyping and molecular biochemical analysis","volume":"60","author":"Owen","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"23","key":"10.1016\/j.dmd.2025.100145_bib28","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3390\/cells12232668","article-title":"Patterns of gene expression, splicing, and allele-specific expression vary among macular tissues and clinical stages of age-related macular degeneration","volume":"12","author":"Shwani","year":"2023","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.dmd.2025.100145_bib29","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1073\/pnas.1901572116","article-title":"Generation, transcriptome profiling, and functional validation of cone-rich human retinal organoids","volume":"116","author":"Kim","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.dmd.2025.100145_bib30","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1038\/s41467-019-12917-9","article-title":"Single-nuclei RNA-seq on human retinal tissue provides improved transcriptome profiling","volume":"10","author":"Liang","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.dmd.2025.100145_bib31","article-title":"A systems biology approach uncovers novel disease mechanisms in age-related macular degeneration","volume":"3","author":"Orozco","year":"2023","journal-title":"Cell Genom"},{"issue":"6","key":"10.1016\/j.dmd.2025.100145_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bcpt.12625","article-title":"Association of oseltamivir activation with gender and carboxylesterase 1 genetic polymorphisms","volume":"119","author":"Shi","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100145_bib33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","article-title":"Human carboxylesterases: a comprehensive review","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"10.1016\/j.dmd.2025.100145_bib34","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1124\/dmd.107.015727","article-title":"Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver","volume":"35","author":"Jewell","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100145_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcp.2016.07.007","article-title":"Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicity","volume":"116","author":"Fukami","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"10.1016\/j.dmd.2025.100145_bib36","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1124\/dmd.110.033720","article-title":"Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.dmd.2025.100145_bib37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0090-9556(25)09205-0","article-title":"Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit","volume":"13","author":"Butler","year":"1985","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.dmd.2025.100145_bib38","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1021\/ic991134k","article-title":"Paraoxon and parathion hydrolysis by aqueous molybdenocene dichloride (Cp2MoCl2): first reported pesticide hydrolysis by an organometallic complex","volume":"39","author":"Kuo","year":"2000","journal-title":"Inorg Chem"},{"issue":"1-2","key":"10.1016\/j.dmd.2025.100145_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0300-9084(96)88110-7","article-title":"The nucleoside deaminases for cytidine and adenosine: structure, transition state stabilization, mechanism, and evolution","volume":"77","author":"Carter","year":"1995","journal-title":"Biochimie"},{"issue":"6743","key":"10.1016\/j.dmd.2025.100145_bib40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"},{"issue":"2 suppl","key":"10.1016\/j.dmd.2025.100145_bib41","first-page":"62","article-title":"Cetrorelix in reproductive medicine","volume":"4","author":"Findeklee","year":"2023","journal-title":"F S Rep"},{"key":"10.1016\/j.dmd.2025.100145_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113921","article-title":"Hepatic in vitro metabolism of peptides; Comparison of human liver S9, hepatocytes and Upcyte hepatocytes with cyclosporine A, leuprorelin, desmopressin and cetrorelix as model compounds","volume":"196","author":"Jyrk\u00e4s","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.dmd.2025.100145_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115219","article-title":"Extrahepatic in vitro metabolism of peptides; comparison of human kidney and intestinal S9 fraction, human plasma and proximal tubule cells, using cyclosporine A, leuprorelin, and cetrorelix as model compounds","volume":"225","author":"Jyrk\u00e4s","year":"2023","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"10.1016\/j.dmd.2025.100145_bib44","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1021\/acs.molpharmaceut.0c00037","article-title":"Prodrug approach for posterior eye drug delivery: synthesis of novel ganciclovir prodrugs and in vitro screening with cassette dosing","volume":"17","author":"Heikkinen","year":"2020","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.dmd.2025.100145_bib45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/pharmaceutics12060570","article-title":"Recent advances in the design of topical ophthalmic delivery systems in the treatment of ocular surface inflammation and their biopharmaceutical evaluation","volume":"12","author":"Mazet","year":"2020","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.dmd.2025.100145_bib46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.molmed.2003.09.005","article-title":"Anandamide hydrolysis: a new target for anti-anxiety drugs?","volume":"9","author":"Gaetani","year":"2003","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.dmd.2025.100145_bib47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0022-3565(24)39042-1","article-title":"Phenacetin deacetylase activity in human liver microsomes: distribution, kinetics, and chemical inhibition and stimulation","volume":"294","author":"Kudo","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.dmd.2025.100145_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1389200219666180821094502","article-title":"The impact of carboxylesterases in drug metabolism and pharmacokinetics","volume":"20","author":"Di","year":"2019","journal-title":"Curr Drug Metab"},{"issue":"5","key":"10.1016\/j.dmd.2025.100145_bib49","first-page":"1189","article-title":"Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2","volume":"60","author":"Humerickhouse","year":"2000","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.dmd.2025.100145_bib50","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.3390\/ijms24086881","article-title":"Paraoxonases at the heart of neurological disorders","volume":"24","author":"Khalaf","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.dmd.2025.100145_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/metabo13020187","article-title":"Role of oxidative stress in ocular diseases: a balancing act","volume":"13","author":"Shu","year":"2023","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.dmd.2025.100145_bib52","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/17425255.2015.985648","article-title":"Role of cytidine deaminase in toxicity and efficacy of nucleosidic analogs","volume":"11","author":"Serdjebi","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"14","key":"10.1016\/j.dmd.2025.100145_bib53","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1055\/a-1665-3100","article-title":"Cannabinoids as new drug candidates for the treatment of Glaucoma","volume":"88","author":"Jordan","year":"2022","journal-title":"Planta Med"},{"issue":"8","key":"10.1016\/j.dmd.2025.100145_bib54","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/ph16081149","article-title":"Therapeutic potential of cannabinoids in glaucoma","volume":"16","author":"Lindner","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"10.1016\/j.dmd.2025.100145_bib55","doi-asserted-by":"crossref","DOI":"10.1042\/NS20170144","article-title":"Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options","volume":"2","author":"Lafreniere","year":"2018","journal-title":"Neuronal Signal"},{"issue":"39","key":"10.1016\/j.dmd.2025.100145_bib56","doi-asserted-by":"crossref","first-page":"35470","DOI":"10.1021\/acsomega.3c02897","article-title":"An update on strategies to deliver protein and peptide drugs to the eye","volume":"8","author":"Boddu","year":"2023","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/j.dmd.2025.100145_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307731","article-title":"Bioinformatic characterization of ENPEP, the gene encoding a potential cofactor for SARS-CoV-2 infection","volume":"19","author":"Arppo","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.dmd.2025.100145_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2009.03.120","article-title":"Regulation of carboxylesterase 1 (CES1) in human adipose tissue","volume":"383","author":"Jern\u00e5s","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.dmd.2025.100145_bib59","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2005.09.002","article-title":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma","volume":"70","author":"Li","year":"2005","journal-title":"Biochem Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:59:48Z","timestamp":1772819988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0090955625091548"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100145","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of hydrolase activity in ocular tissues of humans and preclinical species","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100145"}}